ft 31 jul 92 breakup ici pharmaceut divis enter flat period decad success ici bioscienc demerg year would account 31 per cent group sale 70 per cent profit research spend ici bio take fast grow scienc base busi prop ici fortun recess last two year intern compani closest shape ici bio ciba geigi switzerland also domin larg profit pharmaceut busi larg less profit agrochem busi scatter smaller specialist chemic activ monsanto us sandoz switzerland intern chemic group biolog orient similar ici bio pharmaceut divis ici success oper last decad share gener prosper intern drug industri also contribut best seller particularli treat heart diseas cancer howev analyst believ current rapid growth ici pharmaceut inde half yearli result announc yesterday show drug sale profit margin 1991 best mr ronni hampel ici chief oper offic could say continu expect pharmaceut perform whole year level approach last year pharmaceut sale suffer expiri last year us patent protect tenormin ici best sell heart drug alreadi 30 per cent tenormin prescript replac cheaper gener version atenolol ici least expect lose tenormin revenu year unexpect blow withdraw side effect temafloxacin antibiot compani licens abbott us order fill gap product line posit side sale ici three newest drug zestril heart zoladex cancer diprivan anaesthet third year dr tom mckillop technic director ici pharmaceut say compani strong portfolio drug variou stage develop 10 clinic trial could give ici pharmaceut new burst growth late 1990 rel flat period howev success new drug ici bio may find difficult keep pharmaceut busi run independ medium size player increasingli competit global industri ici number 17 world leagu drug compani term sale analyst predict link competitor merger acquisit comprehens global allianc order maintain strength research develop market last year specul ici wellcom combin would make strateg sens recent wellcom share sale propos demerg ici bio would make easier although restructur agenda intern pharmaceut busi urgent prioriti agrochem industri ici world second largest player ciba geigi curb agricultur product especi europ reduc sale farm chemic lead overcapac ici agrochem strong scientif market base prospect look bright ici seed still much smaller busi agrochem better growth prospect compani develop rang genet engin seed crop rang non squashi tomato herbicid resist corn promis ici bio busi includ quorn fungal food biopol biodegrad plastic made bacteria